N. Sultanbaeva

发表

Spectrum and frequency of BRCA1, BRCA2, CHEK2, PALB2, RAD50 mutations in breast cancer patients in the Republic of Bashkortostan

I. Gilyazova, A. Pushkarev, N. Sultanbaeva, 2020 .

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021, Meditsinskiy sovet = Medical Council.

Neuroendocrine Tumours: a Literature Review

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021, Creative surgery and oncology.

Treatment of advanced small cell lung cancer. Clinical case and literature review

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021 .

Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review

E. Popova, N. Sultanbaeva, K. Menshikov, 2022, Creative surgery and oncology.

Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review

E. Popova, I. Rakhmatullina, N. Sultanbaeva, 2022, Creative surgery and oncology.

Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case)

O. Lipatov, D. Sakaeva, A. Pushkarev, 2021 .

Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study

O. Lipatov, N. Sultanbaeva, A. Nasretdinov, 2022, Journal of Modern Oncology.

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer

A. Pushkarev, N. Sultanbaeva, V. Pushkarev, 2020, Tumors of female reproductive system.

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)

E. Popova, O. Lipatov, N. Sultanbaeva, 2022, Creative surgery and oncology.

Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma

N. Sultanbaeva, K. Menshikov, S. Musin, 2023, Creative surgery and oncology.

Clinical case of the treatment of metastatic luminal breast cancer

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021, Meditsinskiy sovet = Medical Council.

BRCA associated prostate cancer. BRCA heredity of one family

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2022, Cancer Urology.

Case report: treatment of metastatic renal cell carcinoma with nivolumab plus cabozantinib in routine clinical practice

N. Sultanbaeva, K. Menshikov, S. Musin, 2022, Malignant tumours.

The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2022, Journal of Modern Oncology.

Metastatic renal cell carcinoma, the possibility of targeted therapy. Case.

N. Sultanbaeva, K. Menshikov, S. Musin, 2021, Meditsinskiy sovet = Medical Council.

Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene

O. Lipatov, A. Pushkarev, N. Sultanbaeva, 2020, Meditsinskiy sovet = Medical Council.

The role of second-generation EGFR inhibitors in lung cancer therapy in the realities of modern clinical practice

D. Sakaeva, N. Sultanbaeva, A. Nasretdinov, 2021, Onkologiya. Zhurnal imeni P.A.Gertsena.

Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice

N. Sultanbaeva, S. Musin, I. Menshikova, 2023, Creative surgery and oncology.

Renal cell carcinoma with metastases to the external genitalia. Literature review and case report

N. Sultanbaeva, K. Menshikov, S. Musin, 2021, Cancer Urology.

Breast cancer screening in germline mutation carriers. A literature review

O. Lipatov, N. Sultanbaeva, A. Nasretdinov, 2023, Tumors of female reproductive system.

Possibilities of prevention of nausea during cytostatic therapy: literature review and clinical cases

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2023, Meditsinskiy sovet = Medical Council.

Sunitinib in the treatment of advanced renal cell carcinoma

O. Lipatov, N. Sultanbaeva, A. Nasretdinov, 2023, Meditsinskiy sovet = Medical Council.

Immunotherapy of advanced hepatocellular carcinoma: case report and literature review

N. Sultanbaeva, K. Menshikov, S. Musin, 2022, Meditsinskiy sovet = Medical Council.

Predictors of Multiple Primary Malignancies: Literature Review

N. Sultanbaeva, K. Menshikov, S. Musin, 2023, Creative surgery and oncology.

The use of ribociclib in real clinical practice: results of a single-center observational retrospective study

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2024, Meditsinskiy sovet = Medical Council.

Efficacy of the 1st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens

N. Sultanbaeva, K. Menshikov, S. Musin, 2022, Meditsinskiy sovet = Medical Council.

Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2024, Cancer Urology.

Renal cell carcinoma with metastases to the external genitalia. Literature review and case report

N. Sultanbaeva, K. Menshikov, S. Musin, 2021, Cancer Urology.

Quantitative indicators of TREC and KREC excision circles in malignancies: a prospective cohort study

N. Sultanbaeva, K. Menshikov, I. Menshikova, 2024, Journal of Modern Oncology.

The role of G-CSF in the prevention of cytostaticassociated adverse events during antitumor drug therapy

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2024, Meditsinskiy sovet = Medical Council.